The pandemic ushered in a telemedicine boom, with loosened regulations and greater access. Now telehealth and other companies are lobbying hard to keep those gains.
Here & Now‘s Peter O’Dowd talks to Rachel Cohrs, Washington correspondent for our partners at STAT, the health and medicine publication, about what’s at stake for the future of telemedicine.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org. 9(MDEwMDkzMjQzMDEzNDc2MjU4NDA0M2ExOA004))